Metabolic Biomarkers in Type 2 Diabetes: From Discovery to Application

Dear Colleagues,

Metabolic biomarkers provide valuable insights into the underlying pathophysiology and mechanisms of type 2 diabetes (T2DM). Recent research has identified several key biomarkers associated with glucose metabolism, insulin resistance, and lipid profiles. These biomarkers play a crucial role in:

1. Accurate diagnosis of T2DM in the early stages.
2. Predicting disease progression and the risk of complications.
3. Evaluating treatment responses and identifying individuals who may benefit from personalized interventions.
4. Understanding the underlying pathophysiology of T2DM and identifying potential therapeutic targets.

Given the rapid advancements in biomarker research, there is an urgent need to translate these discoveries into clinical practice. This Special Issue seeks to address this gap by inviting submissions that explore the discovery, validation, and application of metabolic biomarkers in T2DM. We welcome original research articles, reviews, and case studies that focus on:

• The identification and validation of novel metabolic biomarkers.
• The use of biomarkers in predicting disease progression and therapeutic responses.
• Clinical trials evaluating biomarker-driven personalized treatment strategies.
• The integration of biomarkers into routine clinical practice and their impact on patient outcomes.

The rationale for this Special Issue is to bridge the current gap between research and practice, facilitating a deeper understanding of T2DM and improving patient care through the effective use of metabolic biomarkers. Despite their potential, challenges such as the validation of biomarkers and their integration into daily clinical practice still require further work. Collaboration between physicians, scientists, and healthcare providers is essential to overcoming these hurdles and advancing the field.

This Special Issue aims to provide a platform for disseminating cutting-edge research and fostering collaboration across disciplines, ultimately contributing to improved management and understanding of T2DM.

Dr. Eiji Kutoh
Dr. Shengshuai Shan
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Metabolites is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.